Taiwan Stock Exchange · Basic Materials
All Cosmos Bio-Tech stock from India: price, numbers and tax
All Cosmos Bio-Tech (4148) is not currently available to trade on Paasa; this guide covers the price, the numbers and the Indian tax treatment.
By Paasa · Updated
All Cosmos Bio-Tech at a glance
- Price
- NT$31.80-NT$0.20 (0.63%)
- Market cap
- NT$2.14B
- Day range
- NT$31.60 – NT$32.00
- P/E
- 11.53
- Dividend yield
- 3.14%
- Volume
- 25.64K
- 1 month
- +2.42%
- 6 months
- -27.06%
- YTD
- -16.97%
- 1 year
- -19.49%
- 5 years
- -5.67%
All Cosmos Bio-Tech statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | NT$2.9B | NT$2.5B | NT$2.8B | NT$3.7B | NT$2.2B |
| Gross profit | NT$829.5M | NT$668.6M | NT$588.0M | NT$1.1B | NT$594.4M |
| Operating income | NT$296.6M | NT$155.9M | NT$189.9M | NT$645.5M | NT$265.6M |
| Net income | NT$153.0M | NT$128.6M | NT$139.4M | NT$368.2M | NT$198.1M |
| Earnings per share | NT$2.28 | NT$2.02 | NT$2.18 | NT$5.75 | NT$3.09 |
| EBITDA | NT$362.6M | NT$312.8M | NT$310.8M | NT$699.8M | NT$373.0M |
| Total assets | NT$4.2B | NT$3.7B | NT$3.7B | NT$4.1B | NT$3.0B |
| Total debt | NT$381.3M | NT$261.6M | NT$543.1M | NT$942.5M | NT$311.3M |
| Cash and short-term investments | NT$1.4B | NT$1.2B | NT$1.7B | NT$1.5B | NT$930.1M |
| Shareholders' equity | NT$2.7B | NT$2.5B | NT$2.3B | NT$2.4B | NT$2.0B |
| Operating cash flow | NT$251.9M | NT$54.2M | NT$959.2M | NT$43.8M | −NT$67.6M |
| Free cash flow | NT$209.1M | −NT$88.1M | NT$795.8M | −NT$17.0M | −NT$171.5M |
| Capital expenditure | −NT$42.8M | −NT$142.2M | −NT$163.4M | −NT$60.9M | −NT$103.8M |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in TWD; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Amia | 8438.TW | NT$80.90 | NT$5.66B |
| Ion Electronic Materials | 6959.TWO | $131.00 | $5.13B |
| Yuen Chang Stainless Steel | 2069.TW | NT$25.75 | NT$4.28B |
| Chitec Technology | 3430.TWO | $111.50 | $3.76B |
| Ways Technical | 3508.TWO | $26.00 | $2.68B |
| Wellpool | 8424.TWO | $70.70 | $2.55B |
| Tycoons Group Enterprise | 2022.TW | NT$7.34 | NT$2.47B |
| Morn Sun Feed Mill | 1240.TWO | $54.10 | $2.39B |
Peers as grouped by the data provider. This is not an investment recommendation.
Why invest in All Cosmos Bio-Tech from India
What All Cosmos Bio-Tech does
All Cosmos Bio-Tech Holding Corporation, through its various operating units, primarily focuses on the production and distribution of bio-organic and bio-chemical compound fertilizers across Malaysia. The company also dedicates efforts to the research and development of microorganisms, particularly for the sustainable management of oil palm waste. All Cosmos Bio-Tech operates in the Agricultural Inputs industry within the Basic Materials sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
How are All Cosmos Bio-Tech dividends taxed for Indian investors?
All Cosmos Bio-Tech trades on the Taiwan Stock Exchange but is domiciled in Malaysia, so any withholding on its dividends follows that country's rules rather than those of Taiwan. Dividends are taxed at your slab rate in India.
What tax do I pay in India when I sell All Cosmos Bio-Tech shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the TWD/INR rate on the day you bought and the day you sold, so the currency move is part of the gain.